Naganathan Girish 4
4 · DEXCOM INC · Filed Nov 14, 2022
Insider Transaction Report
Form 4
DEXCOM INCDXCM
Naganathan Girish
EVP Chief Technology Officer
Transactions
- Award
Common Stock
2022-11-08$0.00/sh+31,449$31→ 31,449 total
Footnotes (2)
- [F1]Represents a grant of restricted stock units that are exempt from Section 16 b-3 and are subject to vesting in four equal annual installments from the date of grant. Share units represent a contingent right to receive one share of DexCom, Inc. Common Stock.
- [F2]Included in this number are 31,449 unvested restricted stock units, 31,449 of which were granted on November 8, 2022 and shall vest through November 8, 2026.